{"id":"https://openalex.org/W2589286309","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.2602","title":"A phase I study of prolonged infusion of triapine in combination with a fixed-dose rate of gemcitabine in patients with advanced solid tumors.","display_name":"A phase I study of prolonged infusion of triapine in combination with a fixed-dose rate of gemcitabine in patients with advanced solid tumors.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2589286309","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.2602","mag":"2589286309"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.2602","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.2602","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.2602","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034278848","display_name":"Amir Mortazavi","orcid":"https://orcid.org/0000-0002-2122-6805","observed_orcids":["https://orcid.org/0000-0002-2122-6805"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Mortazavi","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University and The Comprehensive Cancer Center, A454 Starling-Loving Hall, 320 West 10th Ave, Columbus, OH 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University and The Comprehensive Cancer Center, A454 Starling-Loving Hall, 320 West 10th Ave, Columbus, OH 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I2802841970","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052017737","display_name":"Deidre Deam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Deam","raw_affiliation_strings":["City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y. Ling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. Ling","raw_affiliation_strings":["Pharmacoanalytical Shared Resources, The Ohio State University and The Comprehensive Cancer Center, Columbus, OH 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoanalytical Shared Resources, The Ohio State University and The Comprehensive Cancer Center, Columbus, OH 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E. J. Harper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. J. Harper","raw_affiliation_strings":["Pharmacoanalytical Shared Resources, The Ohio State University and The Comprehensive Cancer Center, Columbus, OH 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoanalytical Shared Resources, The Ohio State University and The Comprehensive Cancer Center, Columbus, OH 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066257150","display_name":"Mitch A. Phelps","orcid":"https://orcid.org/0000-0002-1615-5280","observed_orcids":["https://orcid.org/0000-0002-1615-5280"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. A. Phelps","raw_affiliation_strings":["Pharmacoanalytical Shared Resources, The Ohio State University and The Comprehensive Cancer Center, Columbus, OH 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoanalytical Shared Resources, The Ohio State University and The Comprehensive Cancer Center, Columbus, OH 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014445762","display_name":"Igor Espinoza\u2010Delgado","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. J. Espinoza-Delgado","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103845944","display_name":"J. Paul Monk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. P. Monk","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University and The Comprehensive Cancer Center, A454 Starling-Loving Hall, 320 West 10th Ave, Columbus, OH 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University and The Comprehensive Cancer Center, A454 Starling-Loving Hall, 320 West 10th Ave, Columbus, OH 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I2802841970","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079014774","display_name":"Greg A. Otterson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. A. Otterson","raw_affiliation_strings":["City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110399749","display_name":"Michael R. Grever","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. R. Grever","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University and The Comprehensive Cancer Center, A454 Starling-Loving Hall, 320 West 10th Ave, Columbus, OH 43210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University and The Comprehensive Cancer Center, A454 Starling-Loving Hall, 320 West 10th Ave, Columbus, OH 43210, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I2802841970","https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074891676","display_name":"Tanios Bekaii\u2010Saab","orcid":"https://orcid.org/0000-0001-7721-1699","observed_orcids":["https://orcid.org/0000-0001-7721-1699","https://orcid.org/0000-0003-4653-4537"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"T. Bekaii-Saab","raw_affiliation_strings":["Cancer Therapeutics Evaluation Program, National Cancer Institute, Rockville, MD 20852, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Therapeutics Evaluation Program, National Cancer Institute, Rockville, MD 20852, USA","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5074891676"],"corresponding_institution_ids":["https://openalex.org/I4210140884"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"2602","last_page":"2602"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.399399995803833,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.399399995803833,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.08179999887943268,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.06830000132322311,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triapine","display_name":"triapine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/fixed-dose-rate-infusion","display_name":"fixed dose rate infusion","score":0.8309999704360962},{"id":"https://openalex.org/keywords/ribonucleotide-reductase-inhibitors","display_name":"ribonucleotide reductase inhibitors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7080000042915344},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9440000057220459},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8389999866485596},{"id":"https://openalex.org/keywords/steady-state-concentration","display_name":"steady-state concentration","score":0.7139999866485596},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8320000171661377},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8460000157356262},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7570000290870667},{"id":"https://openalex.org/keywords/heavily-pretreated-patients","display_name":"heavily pretreated patients","score":0.7570000290870667},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6200000047683716},{"id":"https://openalex.org/keywords/de-escalation","display_name":"de-escalation","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8848785161972046},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.801301121711731},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5958097577095032},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.5835359692573547},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5362182855606079},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5183950066566467},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5143826603889465},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.4828351140022278},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4815819263458252},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.45679453015327454},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4221838116645813},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35894906520843506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3515532314777374},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23184040188789368}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.2602","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.2602","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.2602","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320314457","display_name":"Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1555309303","https://openalex.org/W1566909914","https://openalex.org/W1772536836","https://openalex.org/W1795204252","https://openalex.org/W1851869293","https://openalex.org/W1924785021","https://openalex.org/W1931508686","https://openalex.org/W1968200013","https://openalex.org/W1976487179","https://openalex.org/W1981417880","https://openalex.org/W1982622545","https://openalex.org/W1991823030","https://openalex.org/W2004869577","https://openalex.org/W2014366767","https://openalex.org/W2019227458","https://openalex.org/W2026697163","https://openalex.org/W2040885378","https://openalex.org/W2051000943","https://openalex.org/W2055810949","https://openalex.org/W2083315452","https://openalex.org/W2088939951","https://openalex.org/W2092167912","https://openalex.org/W2095287544","https://openalex.org/W2097642908","https://openalex.org/W2097646991","https://openalex.org/W2100417543","https://openalex.org/W2106806844","https://openalex.org/W2118226539","https://openalex.org/W2122937444","https://openalex.org/W2130136918","https://openalex.org/W2140496330","https://openalex.org/W2146014573","https://openalex.org/W2152679644","https://openalex.org/W2239815859","https://openalex.org/W2300371971","https://openalex.org/W2413781613","https://openalex.org/W4251019823"],"related_works":["https://openalex.org/W2064728753","https://openalex.org/W3011562054","https://openalex.org/W2337413313","https://openalex.org/W1982847073","https://openalex.org/W2264501050","https://openalex.org/W2099007229","https://openalex.org/W2146260418","https://openalex.org/W100548313","https://openalex.org/W2265467041","https://openalex.org/W1992906847"],"abstract_inverted_index":{"2602":[0],"Background:":[1],"Triapine":[2],"(T),":[3],"an":[4],"inhibitor":[5],"of":[6,12,67,71,111,118,150,158,169,180,250,303,306,341,348,370],"ribonucleotide":[7],"reductase,":[8],"enhances":[9],"the":[10,16,22,54,126,141,200,212,224,273,301,361,371],"activity":[11,350,367],"gemcitabine":[13],"(G),":[14],"and":[15,64,109,140,148,209,221,237,272,351,368],"synergism":[17],"is":[18,27,286],"most":[19,225],"evident":[20],"when":[21],"pre-exposure":[23],"time":[24,247],"to":[25,36,52,132,248,269,323,363],"T":[26,82,122,159,170,307,325],"prolonged.":[28],"In":[29,293],"addition,":[30],"fixed-dose":[31],"rate":[32],"G":[33,333],"(FDR-G)":[34],"seems":[35],"show":[37],"improved":[38],"clinical":[39],"efficacy":[40],"over":[41,98],"standard":[42],"dose":[43,57,117,133,157,191],"G.":[44],"Therefore,":[45],"a":[46,86,112,151,234,245,342],"phase":[47,317,359],"I":[48],"trial":[49],"was":[50,83,104,128,143,184,197,214,276,311,321,346],"initiated":[51],"assess":[53],"maximum":[55],"tolerated":[56,216],"(MTD),":[58],"dose-limiting":[59],"toxicity":[60],"(DLT),":[61],"pharmacokinetics":[62],"(PK),":[63],"therapeutic":[65],"response":[66,236],"prolonged":[68],"(24-hour)":[69],"infusion":[70,88,305],"T,":[72],"immediately":[73,330],"followed":[74,308,331],"by":[75,93,309,332],"FDR-G.":[76],"Methods:":[77],"On":[78,188],"any":[79],"treatment":[80,213],"day,":[81],"given":[84,105,144],"as":[85,199],"24-hour":[87,304],"followed,":[89],"in":[90,355],"0-2":[91],"hours,":[92],"FDR-G":[94,310],"at":[95,160,360],"1000":[96,334],"mg/m2":[97,335],"100":[99],"minutes.":[100],"Initially,":[101],"this":[102,254],"combination":[103,142,302],"on":[106,137,145],"days":[107,146],"1":[108,147,232],"8":[110],"21-day":[113],"cycle,":[114],"with":[115,155,202,217,244,288,297],"starting":[116,156],"120":[119,270],"mg":[120,162,195,327],"for":[121,173,261],"(Arm":[123,163],"A).":[124],"Later,":[125],"study":[127],"amended":[129],"after":[130],"de-escalation":[131],"level":[134,192],"-":[135],"2":[136,193,339],"arm":[138],"A,":[139],"15":[149],"28-day":[152],"cycle":[153],"regimen":[154],"75":[161,268,326],"B).":[164],"Steady":[165],"state":[166],"concentrations":[167],"(CSS)":[168],"were":[171,259],"measured":[172],"PK":[174,262,284],"analysis.":[175],"Results:":[176],"The":[177,314],"median":[178,246],"number":[179],"prior":[181],"systemic":[182],"therapies":[183],"3":[185],"(range":[186],"0-12).":[187],"Arm":[189],"B,":[190],"(90":[194],"triapine)":[196],"defined":[198],"MTD,":[201],"DLTs":[203],"including":[204],"grade":[205],"4":[206],"thrombocytopenia,":[207],"leukopenia,":[208],"neutropenia.":[210],"Overall,":[211],"well":[215],"mild":[218],"fatigue,":[219],"nausea,":[220],"vomiting":[222],"being":[223],"common":[226],"toxicities.":[227],"Among":[228],"24":[229],"evaluable":[230],"patients,":[231],"had":[233,240],"partial":[235],"12":[238],"(50%)":[239],"stable":[241],"disease":[242],"(SD)":[243],"progression":[249],"3.5":[251],"months.":[252],"At":[253],"point,":[255],"18":[256],"patient":[257],"samples":[258],"evaluated":[260],"analysis":[263],"(T":[264],"doses":[265],"ranging":[266],"from":[267],"mg)":[271],"mean":[274],"CSS":[275],"492":[277],"\u00b1":[278],"200":[279],"nM":[280],"(range,":[281],"241-1,019":[282],"nM).":[283],"profile":[285],"comparable":[287],"previously":[289],"published":[290],"data.":[291],"Conclusions:":[292],"heavily":[294],"pretreated":[295],"patients":[296],"advanced":[298],"solid":[299],"tumors":[300],"generally":[312],"well-tolerated.":[313],"MTD":[315,362],"(recommended":[316],"II":[318],"dose,":[319],"RP2D)":[320],"determined":[322],"be":[324],"(24-hour":[328],"infusion)":[329],"(100-minute":[336],"infusion),":[337],"every":[338],"weeks":[340],"4-week":[343],"cycle.":[344],"There":[345],"evidence":[347],"interesting":[349],"we":[352],"are":[353],"currently":[354],"our":[356],"6-patient":[357],"expansion":[358],"further":[364],"define":[365],"preliminary":[366],"safety":[369],"RP2D.":[372],"Author":[373],"Disclosure":[374],"Employment":[375],"or":[376,380],"Leadership":[377],"Position":[378],"Consultant":[379],"Advisory":[381],"Role":[382],"Stock":[383],"Ownership":[384],"Honoraria":[385],"Research":[386],"Funding":[387],"Expert":[388],"Testimony":[389],"Other":[390],"Remuneration":[391],"Lilly":[392],"NCCN,":[393],"NCI":[394]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-03-03T00:00:00"}